Market Summary
USD1.50-0.01
Delayed-0.66%
CERS Alerts
CERS Stock Price
CERS RSI Chart
CERS Valuation
CERS Price/Sales (Trailing)
CERS Profitability
CERS Fundamentals
CERS Revenue
CERS Earnings
Price Action
52 Week Range
1.474.25
(Low)(High)
Last 7 days
-8.0%
Last 30 days
-14.3%
Last 90 days
-37.5%
Trailing 12 Months
-58.1%
CERS Financial Health
CERS Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for CERS
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-22 | Lucena Ann | bought | 12,637 | 1.685 | 7,500 | - |
2023-08-21 | BJERKHOLT ERIC | bought | 17,151 | 1.7151 | 10,000 | - |
2023-06-07 | MOORE TIMOTHY L. | acquired | 200,000 | 5.00 | 40,000 | - |
2023-06-07 | Lucena Ann | acquired | 200,000 | 5.00 | 40,000 | - |
2023-06-07 | NACHTSHEIM JAMI K | acquired | 200,000 | 5.00 | 40,000 | - |
2023-06-07 | SCHULZE GAIL | acquired | 200,000 | 5.00 | 40,000 | - |
2023-06-07 | Swisher Daniel N JR | acquired | 200,000 | 5.00 | 40,000 | - |
2023-06-07 | BJERKHOLT ERIC | acquired | 200,000 | 5.00 | 40,000 | - |
2023-06-07 | Witney Frank | acquired | 200,000 | 5.00 | 40,000 | - |
2023-05-26 | Swisher Daniel N JR | bought | 9,535 | 1.907 | 5,000 | - |
Which funds bought or sold CERS recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | added | 80.72 | 968,000 | 2,917,000 | -% |
2023-09-01 | Portside Wealth Group, LLC | new | - | 69,501 | 69,501 | 0.01% |
2023-08-23 | WOLVERINE TRADING, LLC | reduced | -82.2 | -169,983 | 31,017 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | sold off | -100 | -175,527 | - | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.16 | -123,920 | 529,554 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 16.00 | -1,247 | 26,898 | -% |
2023-08-16 | CreativeOne Wealth, LLC | sold off | -100 | -72,000 | - | -% |
2023-08-16 | Nuveen Asset Management, LLC | added | 8.92 | -353,919 | 3,265,080 | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | unchanged | - | -103,094 | 497,274 | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | reduced | -37.9 | -893,472 | 946,301 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
CERS Alerts
Schedule 13G FIlings of Cerus
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | baker bros. advisors lp | 9.1% | 16,067,558 | SC 13G/A | |
| Feb 10, 2023 | nikko asset management americas, inc. | 4.04% | 7,171,280 | SC 13G/A | |
| Feb 10, 2023 | ark investment management llc | 10.11% | 17,943,131 | SC 13G/A | |
| Feb 10, 2023 | ark investment management llc | 8.94% | 15,863,384 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 6.14% | 10,900,422 | SC 13G/A | |
| Feb 03, 2023 | sumitomo mitsui trust holdings, inc. | 4.04% | 7,171,280 | SC 13G/A | |
| Jan 31, 2023 | blackrock inc. | 7.1% | 12,594,054 | SC 13G/A | |
| Jan 09, 2023 | primecap management co/ca/ | 4.99% | 8,849,600 | SC 13G/A | |
| Feb 14, 2022 | nikko asset management americas, inc. | 6.69% | 11,529,716 | SC 13G/A | |
| Feb 10, 2022 | primecap management co/ca/ | 5.64% | 9,722,300 | SC 13G/A |
Recent SEC filings of Cerus
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Aug 23, 2023 | 4 | Insider Trading | |
| Aug 23, 2023 | 4 | Insider Trading | |
| Aug 03, 2023 | 10-Q | Quarterly Report | |
| Aug 02, 2023 | 8-K | Current Report |
Peers (Alternatives to Cerus)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
SYK | 108.3B | 19.5B | 3.38% | 36.58% | 39.99 | 5.57 | 10.36% | 30.30% |
ISRG | 101.2B | 6.7B | -0.75% | 50.83% | 71.05 | 15.19 | 11.75% | -0.66% |
BSX | 77.5B | 13.4B | 6.45% | 36.39% | 85 | 5.78 | 8.69% | 3.17% |
BDX | 71.3B | 19.0B | -4.29% | 12.66% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 42.3B | 5.7B | -8.22% | -17.24% | 30.48 | 7.49 | 5.64% | -4.53% |
| MID-CAP | ||||||||
PEN | 9.5B | 937.8M | -2.12% | 37.22% | 325.65 | 10.11 | 16.30% | 250.21% |
SWAV | 7.1B | 616.6M | -12.54% | -24.86% | 29.24 | 11.56 | 69.52% | 343.68% |
GMED | 5.1B | 1.1B | -6.10% | -12.07% | 24.23 | 4.65 | 12.63% | 50.85% |
IRTC | 2.6B | 452.1M | -21.20% | -33.94% | -26.32 | 5.78 | 24.99% | 24.09% |
TNDM | 1.3B | 790.3M | -27.09% | -56.49% | -5.97 | 1.69 | 3.21% | -1604.53% |
| SMALL-CAP | ||||||||
ATEC | 1.6B | 421.8M | -15.15% | 56.11% | -9.32 | 3.69 | 44.49% | -2.43% |
AVNS | 947.4M | 780.7M | -7.75% | -9.65% | -26.32 | 1.21 | 4.68% | -510.17% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
SILK | 609.7M | 162.9M | -27.67% | -61.65% | -11.53 | 3.74 | 42.67% | 12.82% |
Cerus News
Returns for CERS
Cumulative Returns on CERS
-12.7%
10-Year Cumulative Returns
-18.4%
7-Year Cumulative Returns
-27.3%
5-Year Cumulative Returns
-37.8%
3-Year Cumulative Returns
Risks for CERS
What is the probability of a big loss on CERS?
100%
Probability that Cerus stock will be more than 20% underwater in next one year
93.5%
Probability that Cerus stock will be more than 30% underwater in next one year.
58.1%
Probability that Cerus stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does CERS drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Cerus was unfortunately bought at previous high price.
Drawdowns
Financials for Cerus
Income Statement (Last 12 Months)
| Income Statement (Last 12 Months) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 |
| Revenue | 18.1% | 188,315,000 | 159,518,000 | 126,500,000 | 120,605,000 | 116,242,000 | 114,249,000 | 98,911,000 | 96,693,000 | 94,993,000 | 93,774,000 | 84,466,000 | 81,287,000 | 78,889,000 | 76,051,000 | 37,431,000 | 40,971,000 | 42,796,000 | 43,568,000 | 37,453,000 | 36,831,000 | 36,557,000 |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 18,446,000 | 17,721,000 | 16,831,000 |
| Operating Expenses | 1.7% | 147,442,000 | 144,979,000 | 143,156,000 | 139,731,000 | 134,620,000 | 131,425,000 | 129,275,000 | 129,276,000 | 128,703,000 | 126,581,000 | 120,233,000 | 112,801,000 | 105,962,000 | 99,405,000 | 92,491,000 | 87,818,000 | 86,536,000 | 86,325,000 | 87,440,000 | - | - |
| S&GA Expenses | 2.5% | 83,335,000 | 81,288,000 | 77,976,000 | 73,918,000 | 70,272,000 | 67,015,000 | 65,488,000 | 65,329,000 | 65,957,000 | 66,205,000 | 63,874,000 | 61,698,000 | 59,395,000 | 56,841,000 | 54,565,000 | 52,831,000 | 52,539,000 | 52,615,000 | 52,699,000 | - | - |
| EBITDA | 28.1% | -33,522,000 | -46,634,000 | -52,517,000 | -54,528,000 | -54,452,000 | -53,627,000 | -55,654,000 | -59,530,000 | -62,052,000 | -62,716,000 | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Margin | 39.1% | -0.18 | -0.29 | -0.42 | -0.45 | -0.47 | -0.47 | -0.56 | -0.62 | -0.65 | -0.67 | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expenses | 18.4% | 5,831,000 | 4,923,000 | 4,541,000 | 4,192,000 | 3,783,000 | 3,746,000 | 3,754,000 | 3,855,000 | 4,076,000 | 6,065,000 | 6,187,000 | 6,209,000 | 6,017,000 | 4,008,000 | 3,826,000 | 3,863,000 | 3,406,000 | 3,022,000 | 2,668,000 | - | - |
| Earnings Before Taxes | 21.7% | -42,337,000 | -54,057,000 | -59,296,000 | -61,003,000 | -60,523,000 | -59,573,000 | -62,125,000 | -65,961,000 | -68,658,000 | -70,981,000 | -70,285,000 | -66,514,000 | -62,236,000 | -57,335,000 | -52,750,000 | -51,982,000 | -51,966,000 | -56,698,000 | -59,843,000 | - | - |
| EBT Margin | 33.7% | -0.22 | -0.34 | -0.47 | -0.51 | -0.52 | -0.52 | -0.63 | -0.68 | -0.72 | -0.76 | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | 21.3% | -42,779,000 | -54,374,000 | -59,636,000 | -61,338,000 | -60,848,000 | -59,857,000 | -62,399,000 | -66,227,000 | -68,918,000 | -71,244,000 | -70,526,000 | -66,751,000 | -62,471,000 | -57,564,000 | -52,845,000 | -52,071,000 | -55,872,000 | -60,585,000 | -62,600,000 | - | - |
| Net Income Margin | 33.4% | -0.23 | -0.34 | -0.47 | -0.51 | -0.52 | -0.52 | -0.63 | -0.68 | -0.73 | -0.76 | - | - | - | - | - | - | - | - | - | - | - |
| Free Cashflow | 20.7% | -27,615,000 | -34,832,000 | -42,513,000 | -41,141,000 | -41,341,000 | -43,426,000 | -42,131,000 | -61,486,000 | -69,195,000 | -74,434,000 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | -5.0% | 199 | 209 | 218 | 215 | 216 | 222 | 237 | 219 | 223 | 221 | 221 | 213 | 215 | 215 | 166 | 164 | 175 | 176 | 163 | 162 | 152 |
| Current Assets | -7.0% | 151 | 162 | 170 | 165 | 165 | 173 | 187 | 178 | 186 | 181 | 183 | 177 | 179 | 178 | 128 | 126 | 136 | 135 | 147 | 150 | 141 |
| Cash Equivalents | -25.2% | 21.00 | 28.00 | 36.00 | 29.00 | 34.00 | 40.00 | 51.00 | 81.00 | 61.00 | 60.00 | 39.00 | 31.00 | 37.00 | 36.00 | 37.00 | 27.00 | 26.00 | 32.00 | 32.00 | 25.00 | 17.00 |
| Inventory | 10.9% | 41.00 | 37.00 | 29.00 | 28.00 | 28.00 | 29.00 | 27.00 | 29.00 | 31.00 | 24.00 | 23.00 | 19.00 | 18.00 | 22.00 | 19.00 | 21.00 | 17.00 | 16.00 | 14.00 | 13.00 | 13.00 |
| Net PPE | -5.3% | 10.00 | 11.00 | 11.00 | 11.00 | 11.00 | 12.00 | 12.00 | 13.00 | 13.00 | 13.00 | 14.00 | 14.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 16.00 | 8.00 | 3.00 | 2.00 |
| Goodwill | 0% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Liabilities | -1.7% | 147 | 150 | 150 | 141 | 140 | 141 | 152 | 138 | 139 | 128 | 118 | 104 | 101 | 103 | 108 | 104 | 109 | 106 | 79.00 | 70.00 | 61.00 |
| Current Liabilities | -3.2% | 75.00 | 78.00 | 117 | 95.00 | 79.00 | 67.00 | 79.00 | 65.00 | 66.00 | 55.00 | 60.00 | 46.00 | 43.00 | 45.00 | 50.00 | 46.00 | 51.00 | 48.00 | 53.00 | 43.00 | 28.00 |
| Shareholder's Equity | -14.7% | 51.00 | 60.00 | 68.00 | 73.00 | 77.00 | 80.00 | 86.00 | 81.00 | 84.00 | 93.00 | 104 | 109 | 115 | 112 | 57.00 | 61.00 | 66.00 | 70.00 | 85.00 | 92.00 | 90.00 |
| Retained Earnings | -1.3% | -1,036 | -1,022 | -1,007 | -993 | -985 | -976 | -964 | -955 | -942 | -927 | -909 | -895 | -881 | -866 | -850 | -833 | -815 | -797 | -778 | -762 | -748 |
| Additional Paid-In Capital | 0.5% | 1,089 | 1,083 | 1,077 | 1,070 | 1,063 | 1,057 | 1,049 | 1,035 | 1,027 | 1,019 | 1,013 | 1,004 | 995 | 979 | 907 | 894 | 881 | 867 | 864 | 855 | 839 |
| Shares Outstanding | 1.3% | 181 | 178 | 178 | 177 | 177 | 174 | 174 | 172 | 171 | 169 | 168 | 167 | 164 | 157 | 140 | 141 | 138 | 137 | 132 | 130 | 128 |
| Minority Interest | -6.0% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow (Last 12 Months)(In Thousands)
| Cashflow (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | -68.3% | -21,310 | -12,659 | -25,615 | -25,081 | -29,605 | -37,923 | -33,922 | -41,601 | -40,208 | -39,464 | -41,811 | -41,132 | -58,160 | -63,123 | -65,499 | -64,372 | -47,051 | -43,099 | -31,246 | -34,186 | -42,143 |
| Share Based Compensation | 3.0% | 24,412 | 23,699 | 24,456 | 23,739 | 23,863 | 24,664 | 23,571 | 21,756 | 20,710 | 19,608 | 18,029 | 17,006 | 15,755 | 14,188 | 13,312 | 12,427 | 11,503 | 10,957 | 10,394 | 9,926 | 9,646 |
| Cashflow From Investing | 432.6% | 6,000 | -1,804 | 8,464 | -39,209 | -15,414 | -82.00 | 12,688 | 60,580 | 33,471 | 22,019 | -49,558 | -47,759 | -32,351 | -35,185 | 28,185 | 26,011 | 16,513 | 14,080 | -43,848 | -55,683 | -68,547 |
| Cashflow From Financing | -9.9% | 3,429 | 3,804 | 4,192 | 15,833 | 19,330 | 19,255 | 34,294 | 30,483 | 30,073 | 40,587 | 91,783 | 92,980 | 101,875 | 103,038 | 43,487 | 40,402 | 39,724 | 43,057 | 92,751 | 97,684 | 107,198 |
CERS Income Statement
2023-06-30CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Operating expenses: | ||||
| Research and development | $ 19,184 | $ 15,216 | $ 36,568 | $ 29,273 |
| Selling, general and administrative | 20,541 | 19,532 | 42,092 | 40,267 |
| Restructuring | 2,128 | 2,128 | ||
| Total operating expenses | 41,853 | 34,748 | 80,788 | 69,540 |
| Loss from operations | (11,640) | (6,835) | (25,786) | (16,683) |
| Non-operating expense, net: | ||||
| Foreign exchange gain (loss) | 49 | (104) | (144) | (302) |
| Interest expense | (2,181) | (1,348) | (3,793) | (2,728) |
| Other income (expense), net | 539 | (30) | 926 | (812) |
| Total non-operating expense, net | (1,593) | (1,482) | (3,011) | (3,842) |
| Loss before income taxes | (13,233) | (8,317) | (28,797) | (20,525) |
| Provision for income taxes | 98 | 78 | 175 | 154 |
| Net loss | (13,331) | (8,395) | (28,972) | (20,679) |
| Net loss attributable to noncontrolling interest | (56) | (6) | (78) | (6) |
| Net loss attributable to Cerus Corporation | $ (13,275) | $ (8,389) | $ (28,894) | $ (20,673) |
| Net loss per share attributable to Cerus Corporation | ||||
| Basic | $ (0.07) | $ (0.05) | $ (0.16) | $ (0.12) |
| Diluted | $ (0.07) | $ (0.05) | $ (0.16) | $ (0.12) |
| Weighted average shares outstanding: | ||||
| Basic | 180,611 | 176,944 | 179,449 | 175,718 |
| Diluted | 180,611 | 176,944 | 179,449 | 175,718 |
| Product | ||||
| Revenue | $ 38,853 | $ 40,999 | $ 69,827 | $ 78,443 |
| Cost of revenue | 17,515 | 19,718 | 31,202 | 37,794 |
| Gross profit | 21,338 | 21,281 | 38,625 | 40,649 |
| Government Contract | ||||
| Revenue | $ 8,875 | $ 6,632 | $ 16,377 | $ 12,208 |
CERS Balance Sheet
2023-06-30CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 20,635 | $ 35,585 |
| Short-term investments | 63,868 | 66,569 |
| Accounts receivable | 22,175 | 34,426 |
| Current inventories | 40,608 | 29,003 |
| Prepaid and other current assets | 3,650 | 4,561 |
| Total current assets | 150,936 | 170,144 |
| Non-current assets: | ||
| Property and equipment, net | 10,254 | 10,969 |
| Operating lease right-of-use assets | 12,268 | 12,512 |
| Goodwill | 1,316 | 1,316 |
| Restricted cash | 1,793 | 1,773 |
| Other assets | 22,293 | 21,378 |
| Total assets | 198,860 | 218,092 |
| Current liabilities: | ||
| Accounts payable | 37,489 | 33,002 |
| Accrued liabilities | 17,510 | 25,203 |
| Debt – current | 16,542 | 56,159 |
| Operating lease liabilities – current | 2,176 | 2,105 |
| Deferred product revenue | 1,361 | 589 |
| Total current liabilities | 75,078 | 117,058 |
| Non-current liabilities: | ||
| Debt – non-current | 54,838 | 13,644 |
| Operating lease liabilities – non-current | 14,454 | 15,329 |
| Other non-current liabilities | 2,800 | 3,499 |
| Total liabilities | 147,170 | 149,530 |
| Commitments and contingencies | ||
| Stockholders' equity: | ||
| Common stock | 181 | 177 |
| Additional paid-in capital | 1,089,083 | 1,077,341 |
| Accumulated other comprehensive loss | (2,433) | (2,787) |
| Accumulated deficit | (1,036,015) | (1,007,121) |
| Total Cerus Corporation stockholders' equity | 50,816 | 67,610 |
| Noncontrolling interest | 874 | 952 |
| Total liabilities and stockholders' equity | $ 198,860 | $ 218,092 |
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.